Export

Pyridostigmine
Essential medicine status
General description
Pyridostigmine bromide is a cholinesterase inhibitor used in the treatment of myasthenia gravis.
INN
Pyridostigmine bromide
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Myasthenia gravis
Therapeutic equivalent for
Recommendations
Section
Muscle relaxants (peripherally-acting) and cholinesterase inhibitors
  • Parenteral > General injections > IV: 1 mg in 1 mL ampoule (pyridostigmine bromide)
  • Oral > Solid: 60 mg (pyridostigmine bromide)